Director of Business Development, Cell and Gene Therapy Catapult

Michael Bennett is the Director of Business Development at the Cell and Gene Therapy Catapult and a member of the executive management team. In addition to managing worldwide business development, he is responsible for the intellectual property portfolio, legal and contractual obligations of the Cell and Gene Therapy Catapult. An experienced negotiator who has closed tens of multi-million US dollar revenue generating agreements such as in and out licences, collaboration, service and settlement agreements.

Previously Michael has held a number of executive management positions and was the Vice President of Business Development and Licensing for Oxford Gene Technology Ltd, Vice President of Sales and Marketing for Molecular Sensing Plc, Market Manager for Roche Diagnostics and Product Manager for Hybaid after spending four years as a post-doctoral researcher at the University of Bristol and the Royal Free Hospital in London.

He is a chartered biologist (CBiol) holds a BSc (Hons) in Biology from the University of the West of Scotland along with a doctorate (D.Phil) from the University of Oxford.


16 November 2020